MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination
- PMID: 34931927
- DOI: 10.1177/13524585211057512
MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination
Abstract
This case report describes a 59-year-old man with myelin oligodendrocyte glycoprotein (MOG)-positive longitudinal extensive transverse myelitis (LETM) after being vaccinated with the COVID-19 vaccine ChAdOx1 nCoV-19. He presented with urinary retention, gait disturbance, hypoesthesia and brisk reflexes in his lower extremities without paresis. Due to the ineffectiveness of high-dose intravenous methylprednisolone, therapeutic plasma exchange was performed, gradually improving the patient's condition. Vaccination as a trigger for an excessive immunological response seems plausible, though unspecific for the ChAdOx1 nCoV-19 vaccine.
Keywords: COVID-19; ChAdOx1 nCoV-19; Vaxzevria; myelitis; vaccination.
Comment in
-
MOG antibody-associated longitudinal extensive myelitis after Oxford-Astra Zeneca's COVID-19 vaccination.Mult Scler. 2022 Jun;28(7):1163. doi: 10.1177/13524585211066771. Epub 2022 Feb 12. Mult Scler. 2022. PMID: 35152787 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical